Reservoir Neuroscience is an early-stage biotechnology company building a new class of therapy designed to restore the brain's protective barrier — opening a fundamentally new approach to treating neurological disease.
The blood-brain barrier is the brain's first line of defense. When it fails, the consequences reach across nearly every neurological condition. Reservoir is building therapeutics that heal the barrier's integrity — the first approach of its kind.
A therapeutic designed to repair the barrier — addressing the root, not routing around it.
Targeting a pathway others have not, with the potential to apply broadly across CNS disease.
Early-stage discovery focused on a clear path toward the clinic and meaningful patient impact.
The blood-brain barrier protects the brain from everything it shouldn't see. When its integrity breaks down, disease follows. Restoring that barrier is one of the most direct, under-addressed levers in neurology.
Core thesis defined and team assembled around the blood-brain barrier mechanism.
Early-stage discovery work progressing toward preclinical validation.
Building the roadmap from discovery toward first-in-human studies.
For scientists, investors, and partners exploring the blood-brain barrier as a therapeutic frontier.